Amferia AB

Amferia was born in Gothenburg, Sweden, when three PhD researchers who had been collaborating for five years, had the idea to combine their findings. After several conversations among themselves, in 2016 Amferia founders Saba Atefyekta, Anand Kumar Rajasehkaran and Martin Andersson, conceived a new class of antimicrobial material while working at Chalmers University of Technology .

The approach was to utilise antimicrobial peptides—a potent antimicrobial molecule that Saba Atefyekta was investigating for biomaterial applications — in combination with a new amphiphilic hydrogel developed by Anand Rajasekharan for his PhD research on synthetic bone.